Detail akcie Arseus online

Business Summary: Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. The Company specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. It operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Fagron NV revenues increased 12% to EUR763M. Net income increased 1% to EUR70.5M. Revenues reflect Fagron North America segment increase of 26% to EUR308.9M, Fagron Europe segment increase of 3% to EUR284.9M, Fagron South America segment increase of 4% to EUR169.2M. Net income was partially offset by Fagron South America segment income decrease of 11% to EUR19.4M.